Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

LGND Ligand Pharmaceuticals Incorporated

80,36

7,14 (9,75%)

09 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 144/A - Report of proposed sale of securities: [Amend]

Ligand Pharmaceuticals (NASDAQ:LGND)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Ligand Pharmaceuticals Charts.

Ligand Pharmaceuticals (NASDAQ:LGND)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Ligand Pharmaceuticals Charts.

News Ligand Pharmaceuticals Incorporated

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Freitag 1 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 1 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 1 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 1 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 1 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144/A - Report of proposed sale of securities: [Amend]
Donnerstag 29 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 29 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mittwoch 28 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 27 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Ligand Pharmaceuticals Incorporated News-Artikel

Euro vs US Dollar

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen